For individuals living with depression that hasn’t improved with traditional medications, access to advanced treatment options can feel limited, especially in Western Colorado. That’s changing.
Junction Brain Health is now offering Spravato® (esketamine) nasal spray treatment in Grand Junction, CO, expanding access to an FDA-approved option for adults with treatment-resistant depression and certain depressive symptoms associated with major depressive disorder.
This new offering reflects a growing recognition that depression is not one-size-fits-all, and that some patients need additional, specialized care beyond standard antidepressants.
RELATED ARTICLE: Why TMS Solutions Became Junction Brain Health (and What It Means for You)
What Makes Spravato® Different From Traditional Antidepressants?
Spravato® is not a typical daily medication. Unlike standard antidepressants that primarily target serotonin, Spravato® works on the brain’s glutamate system, a pathway involved in mood regulation, neuroplasticity, and stress response.
For many patients, this difference matters. Spravato® is designed for individuals who have tried multiple antidepressants without adequate relief, a group often referred to as having treatment-resistant depression.
Treatment is provided in a certified medical setting, where patients self-administer the nasal spray under supervision and are monitored afterward for safety.
RELATED ARTICLE: Your Spravato® Nasal Spray Questions Answered
Why Access to Spravato® Matters in Grand Junction
Until recently, patients in the Grand Junction area often had to travel long distances for advanced depression treatments. By offering Spravato® locally, Junction Brain Health helps reduce barriers to care, including travel time, cost, and disruption to daily life.
This is especially important for patients whose symptoms affect work, relationships, and overall functioning. Local access allows for continuity of care and closer coordination with referring providers, including primary care physicians, psychiatrists, and OB-GYNs.
Who May Be a Good Candidate for Spravato®?
Spravato® is not appropriate for everyone, but it may be considered for adults who:
- Have not responded adequately to two or more antidepressant medications
- Experience persistent depressive symptoms despite ongoing care
- Need an option that works differently than standard oral medications
- Are receiving care as part of a comprehensive treatment plan
At Junction Brain Health, every patient undergoes a thorough evaluation to determine whether Spravato®, TMS therapy, medication management, or another approach is most appropriate.
RELATED ARTICLE: Mental Health in Mesa County a Community Issue, Not Just Clinical
A Coordinated, Evidence-Based Approach to Care
Spravato® treatment at Junction Brain Health is delivered as part of an integrated model of care. This means patients are supported not just during treatment sessions, but throughout the process, with ongoing assessment, monitoring, and communication.
The goal is not simply symptom reduction, but helping patients regain stability, clarity, and quality of life in a safe, medically guided environment.
RELATED ARTICLE: Dr. Walter Standridge Joins Junction Brain Health in Grand Junction, CO
Common Questions About Spravato® Treatment in Grand Junction
Q. What is Spravato® used to treat?
A. Spravato® is FDA-approved for adults with treatment-resistant depression and certain depressive symptoms in major depressive disorder.
Q. Is Spravato® the same as ketamine?
A. Spravato® contains esketamine, a specific form of ketamine, and is administered under strict medical supervision in certified clinics.
Q. How often do patients receive Spravato® treatment?
A. Treatment typically begins with twice-weekly sessions, followed by a tapering schedule based on clinical response.
Q. Do I have to stop my current antidepressants?
A. Spravato® is usually used in combination with an oral antidepressant, but treatment plans are individualized.
Q. Is Spravato® available near me in Grand Junction, CO?
A. Yes. Junction Brain Health now offers Spravato® treatment at its Grand Junction clinic, providing local access to this FDA-approved therapy.
Q. Is Spravato® safe?
A. Spravato® is FDA-approved and administered only in certified medical settings. Patients are monitored before, during, and after each session to ensure safety.
Q. How quickly does Spravato® work?
A. Some patients notice changes within weeks, though response varies. Ongoing evaluation helps guide the treatment plan.
Q. Do I need a referral for Spravato® treatment?
A. Referrals are welcome but not required. Junction Brain Health works collaboratively with referring providers when involved.
Q. Can Spravato® be combined with other treatments?
A. Yes. Spravato® is often part of a broader care plan that may include medication management, psychotherapy, or TMS therapy.
A New Option for Depression Care in Grand Junction
Living with depression that hasn’t responded to standard treatments can be exhausting and isolating. Opening a Spravato® treatment center in Grand Junction, CO gives patients and providers a new pathway forward, one grounded in evidence, safety, and compassionate care.
At Junction Brain Health, advanced treatments are delivered within a coordinated, medically supervised model designed to support each patient’s unique needs. Whether you are seeking care for yourself or referring a patient who needs additional options, help is now available locally. To learn more about Spravato® treatment or to schedule a consultation, contact Junction Brain Health today.